Prescription drug spending is one of the motivations behind why patients and medical services payers including the Medicare program—follow through on such inordinate costs for drugs. The United States’ patent framework and market eliteness rules safeguard drug makers from ordinary market rivalry, giving these partnerships essentially more prominent dealing power than wellbeing payers. While trying […]
